UNSPSC 85251907: Diagnosis of malignant neoplasm on the malignant melanoma of lower limb, including hip

This classification denotes the group of activities that yields a diagnosis of Malignant neoplasm on the Malignant melanoma of lower limb, including hip. Malignant neoplasm on the Malignant melanoma of lower limb, including hip is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C43. 7

UNSPSC 85251907, Diagnosis of malignant neoplasm on the malignant melanoma of lower limb, including hip, is a Commodity code that shows little relevant recent activity. The three most recent state and local opportunities tagged to this code do not align with its scope: San Mateo Medical Center is soliciting for a diagnostic imaging PACS system (a health IT infrastructure procurement), Birdville Independent School District is seeking special education contracted services across multiple disciplines, and Santa Clara Health System is establishing a vendor pool for temporary health professional staffing spanning audiology, cardiology, diagnostic imaging, gastroenterology, and other ancillary roles. None of these solicitations involves diagnosis or clinical pathology services specific to melanoma of the lower limb or hip, nor do they reflect the direct diagnostic or evaluative work the code nominally describes. The mismatch suggests the code has been applied as a catch-all tag for health-sector opportunities without precision matching to the commodity's actual scope.

The issuing bodies span county health systems (San Mateo, Santa Clara) and school districts (Birdville ISD in Texas), with no state department or specialized cancer diagnostic center visible in the recent record. Geographic activity appears concentrated in California (San Mateo and Santa Clara counties) and Texas (Tarrant County), though the limited sample and coding misalignment make geographic characterization unreliable. Business development professionals should verify the actual scope of any opportunity tagged to this code before investing proposal effort, as the recent record indicates procurement offices may be using it incorrectly or that the code itself does not reflect how state and local governments currently classify diagnostic oncology services.